Regulation of vascular tone from spontaneously hypertensive rats by the HMG-CoA reductase inhibitor, simvastatin

被引：14
|
作者：
Pérez-Guerrero, C [1 ]
Márquez-Martín, A [1 ]
Herrera, MD [1 ]
Marhuenda, E [1 ]
de Sotomayor, MA [1 ]
机构：
[1] Univ Seville, Fac Pharm, Dept Pharmacol, ES-41012 Seville, Spain
来源：
PHARMACOLOGY | 2005年 / 74卷 / 04期
关键词：
HMG-CoA reductase; simvastatin; calcium; Rho-kinase; spontaneously hypertensive rat;
D O I：
10.1159/000085957
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
The acute effect of simvastatin on aortic rings from spontaneously hypertensive rats (SHRs) was identified. Simvastatin-evoked relaxations of both depolarized and phenylephrine-precontracted arteries were independent of the presence of endothelium. This effect was inhibited by diltiazem and mevalonate, but not by the Rho-kinase inhibitor, Y-27632. Simvastatin prevented contraction induced by phenylephrine, calcium ionophore A-23187 and CaCl2 in Ca2+- free medium. Y-27632 decreased the effect of simvastatin. On the contrary, contraction induced by noradrenaline in Ca2+- free medium was not affected. These results suggest that simvastatin elicited an effect on vascular smooth muscle cells from SHRs that may involve blockade of extracellular calcium entry and decrease vascular contraction by affecting Rho-kinase. Copyright (C) 2005 S. Karger AG, Basel.
引用
收藏
页码：209 / 215
页数：7
相关论文
共 50 条
  • [1] Effects of simvastatin, an HMG-CoA reductase inhibitor, in patients with hypertriglyceridemia
    Isaacsohn, J
    Hunninghake, D
    Schrott, H
    Dujovne, CA
    Knopp, R
    Weiss, SR
    Bays, H
    Crouse, JR
    Davidson, MH
    Keilson, LM
    McKenney, J
    Korenman, SG
    Dobs, AS
    Stein, E
    Krauss, RM
    Maccubbin, D
    Cho, M
    Plotkin, DJ
    Mitchel, YB
    CLINICAL CARDIOLOGY, 2003, 26 (01) : 18 - 24
  • [2] SIMVASTATIN - A NEW HMG COA REDUCTASE INHIBITOR
    PIETRO, DA
    MANTELL, G
    CARDIOVASCULAR DRUG REVIEWS, 1990, 8 (03): : 220 - 228
  • [3] Simvastatin: In Vitro Metabolic Profiling of a Potent Competitive HMG-CoA Reductase Inhibitor
    Yin, Wencui
    Alwabli, Reem I.
    Attwa, Mohamed W.
    Rahman, A. F. M. Motiur
    Kadi, Adnan A.
    SEPARATIONS, 2022, 9 (12)
  • [4] Regulation of HMG-CoA reductase in mammals and yeast
    Burg, John S.
    Espenshade, Peter J.
    PROGRESS IN LIPID RESEARCH, 2011, 50 (04) : 403 - 410
  • [5] Dissolution of Gallstones with Simvastatin, an HMG CoA Reductase Inhibitor
    B. A. Chapman
    M. J. Burt
    R. J. Chisholm
    R. B. Allan
    K. H. J. Yeo
    A. G. Ross
    Digestive Diseases and Sciences, 1998, 43 : 349 - 353
  • [6] Dissolution of gallstones with simvastatin, an HMG CoA reductase inhibitor
    Chapman, BA
    Burt, MJ
    Chisholm, RJ
    Allan, RB
    Yeo, KHJ
    Ross, AG
    DIGESTIVE DISEASES AND SCIENCES, 1998, 43 (02) : 349 - 353
  • [7] HMG-CoA Reductase Inhibitor, Simvastatin Is Effective in Decreasing Degree of Myocarditis by Inhibiting Metalloproteinases Activation
    Skrzypiec-Spring, Monika
    Sapa-Wojciechowska, Agnieszka
    Haczkiewicz-Lesniak, Katarzyna
    Piasecki, Tomasz
    Kwiatkowska, Joanna
    Podhorska-Okolow, Marzenna
    Szelag, Adam
    BIOMOLECULES, 2021, 11 (10)
  • [8] THE EFFECT OF THE HMG-COA REDUCTASE INHIBITOR SIMVASTATIN AND OF CHOLESTYRAMINE ON HEPATIC APOLIPOPROTEIN MESSENGER-RNA LEVELS IN THE RAT
    MITCHELL, A
    FIDGE, N
    GRIFFITHS, P
    BIOCHIMICA ET BIOPHYSICA ACTA, 1993, 1167 (01) : 9 - 14
  • [9] Design of Tripeptides as a Competitive Inhibitor for HMG-CoA Reductase
    Valeriy V. Pak
    Dae Yong Kwon
    Olim K. Khojimatov
    Aleksandr V. Pak
    Shomansur Sh. Sagdullaev
    International Journal of Peptide Research and Therapeutics, 2021, 27 : 1923 - 1931
  • [10] Design of Tripeptides as a Competitive Inhibitor for HMG-CoA Reductase
    Pak, Valeriy V.
    Kwon, Dae Yong
    Khojimatov, Olim K.
    Pak, Aleksandr, V
    Sagdullaev, Shomansur Sh
    INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS, 2021, 27 (03) : 1923 - 1931
12345